cytoreductive surgery

You have access
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Outcomes for Colorectal and Mesothelioma Peritoneal Metastases: A 12-year Study
HARLEEN KAUR, GERSHWIN ISAAC SINGH BHALL, CHRISTOPHER LAUDER, NIGEL DA SILVA, TIMOTHY PRICE, MARKUS TROCHSLER, JOSEPHINE WRIGHT, SUSAN LESLEY WOODS and PETER HEWETT

Anticancer Research March 2026, 46 (3) 1507-1515; DOI: https://doi.org/10.21873/anticanres.18045
You have access
Cytoreductive Surgery With or Without Intraperitoneal Chemotherapy for Peritoneal Spread from Appendiceal Neoplasms and Cancers
JUNG WOOK SUH, HWAN NAMGUNG, JAE WON JO, SUNG CHUL LEE and DONG-GUK PARK

Anticancer Research December 2025, 45 (12) 5753-5763; DOI: https://doi.org/10.21873/anticanres.17908
Open Access
Survival Outcomes Post-secondary Cytoreduction in Peritoneal Metastatic Cases from Ovarian Cancer: A Single Institute Study
SHOMA BARAT, NIMA AHMADI, RUWANTHI WIJAYAWARDANA, WINSTON LIAUW and DAVID MORRIS

Anticancer Research October 2025, 45 (10) 4281-4293; DOI: https://doi.org/10.21873/anticanres.17779
Open Access
Factors Limiting Ostomy Reversal After Cytoreductive Surgery for Ovarian Cancer: A Retrospective Study
BEATRIZ NAVARRO SANTANA, FREDERIC GUYON, OCTAVIO ARENCIBIA, GUILLAUME BABIN, EUDALDO TOMMASETTI, DANIEL GONZÁLEZ, SABRINA PIEDIMONTE and ALICIA MARTÍN MARTÍNEZ

Anticancer Research October 2024, 44 (10) 4413-4418; DOI: https://doi.org/10.21873/anticanres.17270
You have access
Continuity Unveiled: Evaluating Cytoreduction Outcomes for Advanced Ovarian Cancer Amidst the COVID-19 Era at an ESGO Designated Centre of Excellence
KONSTANTINOS KITSOS-KALYVIANAKIS, KONSTANTINOS PITSIKAKIS, MARIOS EVANGELOS MAMALIS, EVANGELOS KALAMPOKIS, YONG SHENG TAN, AMUDHA THANGAVELU, TIMOTHY BROADHEAD, DAVID NUGENT, DIEDERICK DEJONG and ALEXANDROS LAIOS

Anticancer Research June 2024, 44 (6) 2645-2652; DOI: https://doi.org/10.21873/anticanres.17071
Open Access
Outcomes for Colorectal Cancer Cases With Peritoneal Metastases Treated With Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A Comparative Analysis of Survival Between Peritoneal Carcinomatosis Scores – PCI in a Single Centre
SHOMA BARAT, RUWANTHI WIJAYAWARDANA and DAVID MORRIS

Anticancer Research August 2023, 43 (8) 3529-3538; DOI: https://doi.org/10.21873/anticanres.16530
Open Access
Comparing Survival Outcomes and Impact of EPIC in Patients Undergoing CRS/HIPEC for Mucinous Appendiceal Neoplasm
MELANIE MERCADO, RAPHAEL SHAMAVONIAN, ERNEST CHENG, NIMA AHMADI and DAVID L. MORRIS

Anticancer Research February 2023, 43 (2) 817-822; DOI: https://doi.org/10.21873/anticanres.16223
You have access
Impact of Macroscopic Tumour Consistency and EPIC in Low-grade Appendiceal Neoplasms With Pseudomyxoma Peritonei
ERNEST CHENG, RAPHAEL SHAMAVONIAN, JASMINE MUI, JOSH KARPES, KERRY CHEN, NIMA AHMADI and DAVID L. MORRIS

Anticancer Research July 2022, 42 (7) 3665-3673; DOI: https://doi.org/10.21873/anticanres.15855
You have access
Rare Histologies and Infrequent Indications for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
ALAEDIN RAJHA, POMPILIU PISO, LASZLO HALMY, IVAN PANCZEL, DAN-SEBASTIAN NEDELCUT, ZOLTAN HEROLD, ATTILA MARCELL SZASZ and MIKLOS ACS

Anticancer Research July 2022, 42 (7) 3681-3692; DOI: https://doi.org/10.21873/anticanres.15857
Open Access
Cytoreductive Surgery and HIPEC for Malignant Peritoneal Mesothelioma: Outcomes and Survival From an Australian Centre
RAPHAEL SHAMAVONIAN, ERNEST CHENG, JOSH B. KARPES, SHOMA BARAT, NIMA AHMADI and DAVID L. MORRIS

Anticancer Research June 2022, 42 (6) 2939-2944; DOI: https://doi.org/10.21873/anticanres.15776

Main menu

User menu

Search

cytoreductive surgery

Pages